Epigenetic targeting of DNA damage response (DDR)-related mechanisms to overcome acquired cisplatin resistance of tumor cells.

Jingzhuda (entinostat) - EOC Pharma, EddingPharm

Zolinza (vorinostat) - Merck (MSD)

cisplatin - Generic mfg.

rocilinostat (ACY-1215) - Regenacy

http://www.ncbi.nlm.nih.gov/pubmed/40614869

Daniel Lengle; Fabian Fischer; Gerhard Fritz; Lena Abbey; Marlena Sekeres; Matthias Ulrich Kassack; Thomas Kurz

Jul 5, 2025